Berberine reduces the occurrence of neonatal necrotizing enterocolitis by reducing the inflammatory response

Jing,Yong; Peng,Fudong; Shan,Yufeng; Jiang,Jingkai

doi:10.3892/etm.2018.6871

Berberine reduces the occurrence of neonatal necrotizing enterocolitis by reducing the inflammatory response

Authors:
- Yong Jing
- Fudong Peng
- Yufeng Shan
- Jingkai Jiang
View Affiliations

Affiliations: Department of Pediatric Surgery, The Second People's Hospital of Liaocheng, Linqing, Shandong 252600, P.R. China, Neonatal Intensive Care Unit, The Second People's Hospital of Liaocheng, Linqing, Shandong 252600, P.R. China
Published online on: October 17, 2018 https://doi.org/10.3892/etm.2018.6871
Pages: 5280-5285

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Necrotizing enterocolitis (NEC) is a life‑threatening disease that occurs in premature infants. The aim of the present study was to investigate the effects of berberine, an isoquinoline alkaloid mainly used to treat digestive diseases, in a rat model of NEC. NEC models were established in newborn rats via inhalation of N2 for 90 sec every 4 h and oral administration of 4 mg/kg/day lipopolysaccharides on days 0 and 1. Berberine was administered via oral gavage. In the NEC model group, Toll‑like receptor (TLR)4, nuclear factor NF‑κB (NF‑κB), inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF)‑α, interleukin (IL)‑6 and IL‑10 were upregulated. Symptoms of NEC in the berberine intervention group were significantly relieved, with a clear reduction in the incidence of NEC compared with the NEC group. TLR4, NF‑κB, iNOS, TNF‑α, IL‑6 and IL‑10 expression was decreased following berberine intervention. Furthermore, the expression of mucin‑2 (MUC2) and RNA polymerase σ factor SigA (SIgA) were decreased in the NEC model group and increased following berberine intervention, when compared with the untreated group. It was also demonstrated that the incidence of NEC was reduced following berberine administration, possibly owing to changes in the inflammatory responses. The results of the current study support a potential therapeutic role of berberine for the treatment of NEC.

View Figures

View References

1	Hackam DJ and Sodhi CP: Toll-like receptor-mediated intestinal inflammatory imbalance in the pathogenesis of necrotizing enterocolitis. Cell Mol Gastroenterol Hepatol. 6:229–238.e1. 2018. View Article : Google Scholar : PubMed/NCBI
2	Halpern MD and Denning PW: The role of intestinal epithelial barrier function in the development of NEC. Tissue Barriers. 3:e10007072015. View Article : Google Scholar : PubMed/NCBI
3	Dvorak B, Halpern MD, Holubec H, Williams CS, McWilliam DL, Dominguez JA, Stepankova R, Payne CM and McCuskey RS: Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol. 282:G156–G164. 2002. View Article : Google Scholar : PubMed/NCBI
4	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
5	Liu T, Zhang L, Joo D and Sun SC: NF-κB signaling in inflammation. Signal Transduct Target Ther. 2:2017.
6	Martin NA, Mount Patrick SK, Estrada TE, Frisk HA, Rogan DT, Dvorak B and Halpern MD: Active transport of bile acids decreases mucin 2 in neonatal ileum: Implications for development of necrotizing enterocolitis. PLoS One. 6:e271912011. View Article : Google Scholar : PubMed/NCBI
7	Tian F, Liu GR, Li N and Yuan G: YUAN4 insulin-like growth factor I reduces the occurrence of necrotizing enterocolitis by reducing inflammatory response and protecting intestinal mucosal barrier in neonatal rats model. Eur Rev Med Pharmacol Sci. 21:4711–4719. 2017.PubMed/NCBI
8	Garg BD, Sharma D and Bansal A: Biomarkers of necrotizing enterocolitis: A review of literature. J Matern Fetal Neonatal Med. 31:3051–3064. 2017. View Article : Google Scholar : PubMed/NCBI
9	Rai SE, Sidhu AK and Krishnan RJ: Transfusion-associated necrotizing enterocolitis re-evaluated: A systematic review and meta-analysis. J Perinat Med. 46:665–676. 2018. View Article : Google Scholar : PubMed/NCBI
10	De Plaen IG: Inflammatory signaling in necrotizing enterocolitis. Clin Perinatol. 40:109–124. 2013. View Article : Google Scholar : PubMed/NCBI
11	Frost BL, Jilling T and Caplan MS: The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis. Semin Perinatol. 32:100–106. 2008. View Article : Google Scholar : PubMed/NCBI
12	MohanKumar K, Namachivayam K, Chapalamadugu KC, Garzon SA, Premkumar MH, Tipparaju SM and Maheshwari A: Smad7 interrupts TGF-β signaling in intestinal macrophages and promotes inflammatory activation of these cells during necrotizing enterocolitis. Pediatr Res. 79:951–961. 2016. View Article : Google Scholar : PubMed/NCBI
13	Claud EC: Neonatal necrotizing enterocolitis-inflammation and intestinal immaturity. Antiinflamm Antiallergy Agents Med Chem. 8:248–259. 2009. View Article : Google Scholar : PubMed/NCBI
14	Zani A and Pierro A: Necrotizing enterocolitis: Controversies and challenges. F1000Res. 4:F1000 Faculty Rev. –1373. 2015.PubMed/NCBI
15	Maheshwari A, Schelonka RL, Dimmitt RA, Carlo WA, Munoz-Hernandez B, Das A, McDonald SA, Thorsen P, Skogstrand K, Hougaard DM, et al: Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infants. Pediatr Res. 76:100–108. 2014. View Article : Google Scholar : PubMed/NCBI
16	Benkoe T, Baumann S, Weninger M, Pones M, Reck C, Rebhandl W and Oehler R: Comprehensive evaluation of 11 cytokines in premature infants with surgical necrotizing enterocolitis. PLoS One. 8:e587202013. View Article : Google Scholar : PubMed/NCBI
17	Habtemariam S: Berberine and inflammatory bowel disease: A concise review. Pharmacol Res. 113:592–599. 2016. View Article : Google Scholar : PubMed/NCBI
18	Cicero AF and Baggioni A: Berberine and its role in chronic disease. Adv Exp Med Biol. 928:27–45. 2016. View Article : Google Scholar : PubMed/NCBI
19	Zhou X, Ren F, Wei H, Liu L, Shen T, Xu S, Wei J, Ren J and Ni H: Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats. Lipids Health Dis. 16:2392017. View Article : Google Scholar : PubMed/NCBI
20	Shinyama S, Kaji T, Mukai M, Nakame K, Matsufuji H, Takamatsu H and Ieiri S: The novel preventive effect of Daikenchuto (TJ-100), a Japanese herbal drug, against neonatal necrotizing enterocolitis in rats. Pediatr Surg Int. 33:1109–1114. 2017. View Article : Google Scholar : PubMed/NCBI
21	Patel RM and Underwood MA: Probiotics and necrotizing enterocolitis. Semin Pediatr Surg. 27:39–46. 2018. View Article : Google Scholar : PubMed/NCBI
22	Harpavat S, Pammi M and Gilger M: Novel treatments for NEC: Keeping IBD in mind. Curr Gastroenterol Rep. 14:373–379. 2012. View Article : Google Scholar : PubMed/NCBI
23	Jiang F, Meng D, Weng M, Zhu W, Wu W, Kasper D and Walker WA: The symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis inhibits IL-1beta-induced inflammation in human fetal enterocytes via toll receptors 2 and 4. PLoS One. 12:e01727382017. View Article : Google Scholar : PubMed/NCBI
24	Dolasia K, Bisht MK, Pradhan G, Udgata A and Mukhopadhyay S: TLRs/NLRs: Shaping the landscape of host immunity. Int Rev Immunol. 37:3–19. 2018. View Article : Google Scholar : PubMed/NCBI
25	Mohammadi S, Seyedhoseini FS, Asadi J and Yazdani Y: Effects of berberine on the secretion of cytokines and expression of genes involved in cell cycle regulation in THP-1 monocytic cell line. Iran J Basic Med Sci. 20:530–537. 2017.PubMed/NCBI
26	Fang C, Xie L, Liu C, Fu C, Ye W, Liu H and Zhang B: Berberine ameliorates neonatal necrotizing enterocolitis by activating the phosphoinositide 3-kinase/protein kinase B signaling pathway. Exp Ther Med. 15:3530–3536. 2018.PubMed/NCBI
27	Nanthakumar N, Meng D, Goldstein AM, Zhu W, Lu L, Uauy R, Llanos A, Claud EC and Walker WA: The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: An immature innate immune response. PLoS One. 6:e177762011. View Article : Google Scholar : PubMed/NCBI
28	Dong XS, Xu XY, Sun YQ, Wei-Liu, Jiang ZH and Liu Z: Toll-like receptor 4 is involved in myocardial damage following paraquat poisoning in mice. Toxicology. 312:115–122. 2013. View Article : Google Scholar : PubMed/NCBI
29	Hong JT: NF-kB as a mediator of brain inflammation in AD. CNS Neurol Disord Drug Targets. 2017.
30	Liu Q, Xu D, Jiang S, Huang J, Zhou F, Yang Q, Jiang S and Yang L: Toll-receptor 9 gene in the black tiger shrimp (Penaeus monodon) induced the activation of the TLR-NF-κB signaling pathway. Gene. 639:27–33. 2018. View Article : Google Scholar : PubMed/NCBI
31	Qi W, Shen Q, Zhang L, Han LP and Wang S: Study on the inflammatory intervention of erythropoietin on NEC. Exp Ther Med. 11:2221–2224. 2016. View Article : Google Scholar : PubMed/NCBI
32	Satoh T, Izumi H, Iwabuchi N, Odamaki T, Namba K, Abe F and Xiao JZ: Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat model. Benef Microbes. 7:75–82. 2016. View Article : Google Scholar : PubMed/NCBI
33	Sicard JF, Le Bihan G, Vogeleer P, Jacques M and Harel J: Interactions of intestinal bacteria with components of the intestinal mucus. Front Cell Infect Microbiol. 7:3872017. View Article : Google Scholar : PubMed/NCBI
34	Betge J, Schneider NI, Harbaum L, Pollheimer MJ, Lindtner RA, Kornprat P, Ebert MP and Langner C: MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: Expression profiles and clinical significance. Virchows Arch. 469:255–265. 2016. View Article : Google Scholar : PubMed/NCBI
35	Chatterton DE, Nguyen DN, Bering SB and Sangild PT: Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int J Biochem Cell Biol. 45:1730–1747. 2013. View Article : Google Scholar : PubMed/NCBI